Which types of non-bleeding visible vessels in gastric peptic ulcers should be treated by endoscopic hemostasis?

被引:7
作者
Amano, Y
Moriyama, N
Suetsugu, H
Ishimura, N
Imaoka, T
Komazawa, Y
Fujishiro, H
Ishihara, S
Adachi, K
Kinoshita, Y
机构
[1] Shimane Med Univ, Dept Gastroenterol Endoscopy, Izumo, Shimane 6938501, Japan
[2] Shimane Med Univ, Dept Med 2, Izumo, Shimane 6938501, Japan
[3] Shimane Prefectural Cent Hosp, Dept Gastroenterol, Izumo, Shimane, Japan
关键词
D O I
10.1111/j.1440-1746.2004.03189.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Because non-bleeding visible vessels (NBVV) of gastric peptic ulcers have the potential to re-bleed, endoscopic hemostatic treatment may be necessary during the first emergency endoscopy. However, not all NBVV re-bleed, and endoscopic hemostasis sometimes causes fatal side-effects. Therefore, we have evaluated the risk of re-bleeding from various NBVV in gastric peptic ulcers to determine which types should be treated by endoscopy to prevent re-bleeding. Methods: A total of 227 NBVV in 202 patients with gastric peptic ulcers that were endoscopically followed without endoscopic hemostatic procedures were classified by the following factors: vessel color, form, location of the NBVV in the ulcer crater, and location of the ulcer in the stomach. The re-bleeding rate was then analyzed for each type of NBVV. Results: Significantly high rates of re-bleeding were observed in cases with white, protruded and peripheral NBVV. In particular, white NBVV located in the peripheral zone of the ulcer crater were frequent re-bleeding sources. The location of the ulcer in the stomach was not a statistically significant factor in determining re-bleeding rates. Conclusion: We found that white, protruded and peripherally located NBVV in gastric ulcers have a higher chance of re-bleeding if preventive endoscopic hemostatic procedures are not performed. (C) 2004 Blackwell Publishing Asia Pty Ltd.
引用
收藏
页码:13 / 17
页数:5
相关论文
共 31 条
[1]
Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers [J].
Adachi, K ;
Suetsugu, H ;
Moriyama, N ;
Kazumori, H ;
Kawamura, A ;
Fujishiro, H ;
Sato, H ;
Okuyama, T ;
Ishihara, S ;
Watanabe, M ;
Kinoshita, Y .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (11) :1211-1216
[2]
ENDOSCOPIC HEMOSTASIS OF GASTROINTESTINAL HEMORRHAGE BY LOCAL APPLICATION OF ABSOLUTE ETHANOL - A CLINICAL-STUDY [J].
ASAKI, S ;
NISHIMURA, T ;
SATOH, A ;
OHARA, S ;
SHIBUYA, D ;
OGITSU, Y ;
GOTO, Y .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 141 (04) :373-383
[3]
BERSTAD A, 1982, SCAND J GASTROENTERO, V17, P103
[4]
SITE AND SIZE OF BLEEDING PEPTIC-ULCER - IS THERE ANY RELATION TO THE EFFICACY OF HEMOSTATIC SCLEROTHERAPY [J].
BRULLET, E ;
CAMPO, R ;
BEDOS, G ;
BARCONS, S ;
GUBERN, JM ;
BORDAS, JM .
ENDOSCOPY, 1991, 23 (02) :73-75
[5]
The visible vessel on the bleeding gastric ulcer: An endoscopic-pathological study [J].
Chen, JJ ;
Changchien, CS ;
Lin, CC ;
Chang, WC .
ENDOSCOPY, 1997, 29 (09) :821-826
[6]
CHEN L-T, 1989, Kaohsiung Journal of Medical Sciences, V5, P180
[7]
Epinephrine or epinephrine plus alcohol for injection of bleeding ulcers: A prospective randomized trial [J].
Chung, SCS ;
Leong, HT ;
Chan, ACW ;
Lau, JYW ;
Yung, MY ;
Leung, JWC ;
Li, AKC .
GASTROINTESTINAL ENDOSCOPY, 1996, 43 (06) :591-595
[8]
THE NONBLEEDING VISIBLE VESSEL VERSUS THE SENTINEL CLOT - NATURAL-HISTORY AND RISK OF REBLEEDING [J].
FREEMAN, ML ;
CASS, OW ;
PEINE, CJ ;
ONSTAD, GR .
GASTROINTESTINAL ENDOSCOPY, 1993, 39 (03) :359-366
[9]
FULLARTON GM, 1991, ALIMENT PHARM THERAP, V5, P77
[10]
PREDICTIVE CLINICAL FACTORS OF VISIBLE VESSEL IN BLEEDING PEPTIC-ULCER [J].
FUSTER, F ;
PIQUE, JM ;
TERES, J ;
BORDAS, JM ;
PEREZ, RM ;
RODES, J .
ENDOSCOPY, 1987, 19 (01) :11-13